Skip to content

Clinical trials

Retinitis Pigmentosa trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20122
20141
20151
20171
20191
20201
20212
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting4
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QLT Inc.4
Jaeb Center for Health Research3
Laboratoires Thea2
Johns Hopkins University1
MeiraGTx UK II Ltd1
Ocugen1
ProQR Therapeutics1
University Health Network, Toronto1
University of Waterloo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa15
Usher Syndromes4
Eye Diseases3
Eye Diseases, Hereditary3
Leber Congenital Amaurosis3
Retinal Diseases3
Vision Disorders3
Eye Abnormalities2
Cone-Rod Dystrophies1
Genetic Diseases, Inborn1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.